Association between tea ingestion and invasive Bacillus cereus infection among children with cancer

Clinical Infectious Diseases

Volumn 39, Issue 10, 2004, Pages 1536-1539

  El Saleeby, Chadi M ^a   Howard, S C ^a   Hayden, R T ^a   McCullers, Jon A ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BACILLUS CEREUS; BACTEREMIA; BACTERIAL INFECTION; BACTERIAL TRANSMISSION; BONE MARROW TRANSPLANTATION; CASE CONTROL STUDY; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; DISEASE PREDISPOSITION; FEMALE; HUMAN; IMMUNE DEFICIENCY; INFECTION RISK; MALE; PATHOGENESIS; PRIORITY JOURNAL; TEA;

ADOLESCENT; ADULT; BACILLUS CEREUS; BACTEREMIA; BEVERAGES; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; INFANT; MALE; NEOPLASMS;

EID: 8744295069     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/425358     Document Type: Article

References (15)

1. Henrickson KJ, Shenep JL, Flynn PM, Pui CH. Primary cutaneous Bacillus cereus infection in neutropenic children. Lancet 1989; 1:601-3.
2. Arnaout MK, Tamburro RF, Bodner SM, et al. Bacillus cereus causing fulminant sepsis and hemolysis in two patients with acute leukemia. J Pediatr Hematol Oncol 1999; 21:431-5.
3. Gaur AH, Patrick CC, McCullers JA, et al. Bacillus cereus bacteremia and meningitis in immunocompromised children. Clin Infect Dis 2001; 32:1456-62.
4. Isogai E, Isogai H, Takeshi K, Nishikawa T. Protective effect of Japanese green tea extract on gnotobiotic mice infected with an Escherichia coli O157:H7 strain. Microbiol Immunol 1998; 42:125-8.
5. Guleria RS, Jain A, Tiwari V, Misra MK. Protective effect of green tea extract against the erythrocytic oxidative stress injury during Mycobacterium tuberculosis infection in mice. Mol Cell Biochem 2002; 236: 173-81.
6. Mondello F, De Bernardis F, Girolamo A, Salvatore G, Cassone A. In vitro and in vivo activity of tea tree oil against azole-susceptible and -resistant human pathogenic yeasts. J Antimicrob Chemother 2003; 51:1223-9.
7. Weber JM, Ruzindana-Umunyana A, Imbeault L, Sircar S. Inhibition of adenovirus infection and adenain by green tea catechins. Antiviral Res 2003; 58:167-73.
8. Cheng HY, Lin CC, Lin TC. Antiviral properties of prodelphinidin B-2 3′-O-gallate from green tea leaf. Antivir Chem Chemother 2002; 13: 223-9.
9. Kawai K, Tsuno NH, Kitayama J, et al. Epigallocatechin gallate, the main component of tea polyphenol, binds to CD4 and interferes with gp120 binding. J Allergy Clin Immunol 2003; 112:951-7.
10. Satchell AC, Saurajen A, Bell C, Barnetson RS. Treatment of interdigital tinea pedis with 25% and 50% tea tree oil solution: a randomized, placebo-controlled, blinded study. Australas J Dermatol 2002; 43:175-8.
11. Lindenmuth GF, Lindenmuth EB. The efficacy of echinacea compound herbal tea preparation on the severity and duration of upper respiratory and flu symptoms: a randomized, double-blind placebo-controlled study. J Altern Complement Med 2000; 6:327-34.
12. Yamada H, Ohashi K, Atsumi T, et al. Effects of tea catechin inhalation on methicillin-resistant Staphylococcus aureus in elderly patients in a hospital ward. J Hosp Infect 2003; 53:229-31.
13. Yamashita S, Yokoyama K, Matsumiya N, Yamaguchi H. Successful green tea nebulization therapy for subglottic tracheal stenosis due to MRSA infection. J Infect 2001; 42:222-3.
14. Hauer T, Jonas D, Dettenkofer M, Daschner FD. Tea as a source of Acinetobacter baumannii ventilator-associated pneumonia? Infect Control Hosp Epidemiol 1999; 20:594.
15. Kusminsky G, Dictar M, Arduino S, Zylberman M, Sanchez Avalos JC. Do not drink mate: an additional source of infection in South American neutropenic patients. Bone Marrow Transplant 1996; 17:127.